A growing phenomenon within the cord blood industry is the use of strategic alliances. This is not surprising, because it is valuable for cord blood banks to establish collaborative relationships with doctors, hospitals, birthing centers, insurance companies, government entities, medical researchers, public and private donors, and more. However, the terms and scope of key strategic alliances within the cord blood industry are often kept quiet. Other times, the partnerships are well-known within a specific region, but not publicized on a global basis.
For this reason, five key alliances that substantially impact the cord blood industry are explored below. [Read more…]
Leiden and Oss, The Netherlands, May 30th, 2017 – Pluriomics and Pivot Park Screening Centre announced a collaboration to improve Pluriomics’ cardiovascular drug discovery service offerings and to expand Pivot Park Screening Centre’s knowledge about new and innovative assay technologies used to accelerate drug discoveries. Giving Pluriomics access to the Screening Centre’s ultra High Throughput Screening (uHTS) capability, this collaboration will serve Pluriomics’ mission which is to contribute to the efficiency of the drug discovery and development process by reducing the development length, costs and late stage attrition of novel drug candidates.
